Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients
Clinical trial NCT02730130 · COMPLETED
Trial details
- NCT number
- NCT02730130
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-03
- Primary completion
- 2017-09-26
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.